Vol.22 No.6

Erratum

Erratum to: Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity

Authors

Masayoshi Harigai1,2 , Tsutomu Takeuchi3 , Yoshiya Tanaka4 , Tsukasa Matsubara5 , Hisashi Yamanaka6 , Nobuyuki Miyasaka2,7

  • Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
  • Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
  • Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, Keio University, Tokyo, Japan
  • The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
  • Matsubara Mayflower Hospital, Hyogo, Japan
  • Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
  • Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo, Japan
Received:

Accepted:

Published online:

14 March 2012

Full Text

PDF　(member's only)

Abstract

Without Abstract

Key words